We are hiring for multiple positions
COVID-19 has not slowed our critical research mission. Join our team
Research opportunity for people with Down syndrome who have an immune skin condition
Our newest research initiative is an NIH-funded clinical trial testing the safety and efficacy of a drug called tofacitinib
Improving the lives of people with Down syndrome through advanced biomedical research
Over 50 teams of researchers are working across the CU campuses on numerous exciting projects
We use state-of-the-art, transformational research platforms to decipher the unique biology and disease spectrum caused by trisomy of chromosome 21.
Our ultimate goal is to enable precision medicine approaches to improve health outcomes in Down syndrome, including the development of new diagnostic and therapeutic tools.
CU Scientists Secure $1 Million to Explore COVID-19 and Down Syndrome
NIH and Fast Grants Award $1M to the Crnic Institute to Study COVID-19 in People With Down Syndrome
Sie Center and University researchers investigate corneal morphology in young individuals with Down syndrome
Hyper Immune System May Be Key to Down Syndrome Symptoms
We are the largest geographical cluster of Down syndrome researchers in the world
Comprised of over 50 Principal Investigators and countless more contributing scientists from across the University of Colorado campuses, our researchers bring expertise from a variety of fields.
Together, we are working to decipher the complex mechanisms and multi-faceted health impacts of trisomy 21.
